Small-Cap Snapshot: ADMA Biologics shares rise after FDA accepts its drug application amendment

The biotech acquired the drug Bivigam in an acquisition but production stopped while the facility was renovated

Scientist in a lab
Bivigam is a treatment for immune system disorders

Supervalu Inc (NYSE:SVU) is a top gainer following a US$2.9bn buyout deal from United Natural Foods Inc (NASDAQ:UNFI). The grocery retailer is the primary supplier of Amazon.com Inc’s Whole Foods. Shareholders will receive US$32.50 per share in cash. Shares of the Minnesota-based company were up nearly 65% to US$32.02 in Thursday morning trading.

ADMA Biologics Inc (NASDAQ:ADMA) shares are up following the announcement that the US Food and Drug Administration accepted its amendment to its drug application. The biotech acquired the drug Bivigam, a treatment for immune disorders, in an acquisition. Production stopped while the facility was shut down and renovated. Shares of the New Jersey-based company were up more than 18% to US$5.86.

Genprex Inc (NASDAQ:GNPX) inked a deal with the University of Texas MD Anderson Cancer Center. The pair will work together on a study of its drug Oncoprex, administering it alongside immunotherapies. The clinical-stage gene therapy company will pay the university center US$2mln to conduct the study. Shares of the company were down around 1.5% to US$6.99.

READ: Small-Cap Snapshot: Medical device company Nevro is on the rise after a court rules in its favor

MoSys Inc (NASDAQ:MOSY) was a top decliner after announcing it would soon lose a major customer. The semiconductor company reported earnings of US$0.06 per share compared with an earnings loss of US$0.42 in its previous second quarter. However, news that an unnamed customer would be phasing out its products in the next 24 months offset the positive results. Shares fell more than 40% to US$1.21.

LSB Industries Inc (NYSE:LXU) shares sank as downtime at the chemical maker’s factories weighed on its second-quarter results. The company reported a net loss of US$27.5mln compared with a loss of US$7mln in its previous second quarter. Its El Dorado ammonia facility in Arkansas was out of service after a power outage caused tube failures. Shares of the Oklahoma-based company were down more than 15% to US$6.53.

The Russell 2000 small-cap index was up slightly in Thursday afternoon trading.

Quick facts: MoSys

Price: $2.46

Market: NASDAQ
Market Cap: $5.35 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Full interview: Gatling Exploration is well funded and increasing their...

Gatling Exploration (CVE: GTR) President and CEO Nav Dhaliwal sat down with Steve Darling from Proactive Vancouver with news Gatling has increased their drill program to 35,000 metres. Dhaliwal talked about where they are targeting with this new beefed-up program.  Dhaliwal also told...

19 hours, 45 minutes ago

2 min read